Blood & Marrow Stem Cell Transplantation: Our Clinical Trials

Title	Investigator
A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and Stem Cell Transplantation in Patients with B-cell Non-Hodgkin's Lymphoma [Protocol 06-150]	Castro-Malaspina, Hugo, MD
A Phase II Study of Maribavir to Treat Resistant Cytomegalovirus Infection in Transplant Recipients [Protocol 12-281]	Papanicolaou, Genovefa, MD
A Phase II Study of Palifermin with or without Leuprolide After T-Cell-Depleted Allogeneic Stem Cell Transplantation [Protocol 12-077]	Goldberg, Jenna, MD
A Pilot Study of Acupuncture to Control Symptoms in Patients Receiving Stem Cell Transplantation for Multiple Myeloma [Protocol 13-038]	Deng, Gary, MD, PhD
A Reduced Intensity Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Acute Leukemia or Myelodysplasia [Protocol 08-087]	Barker, Juliet, MBBS
A Study of Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post-Transplantation Donor Lymphocyte Infusions for Patients with Relapsed or High-Risk Multiple Myeloma [Protocol 10-051]	Koehne, Guenther, MD, PhD
A Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma [Protocol 09-171]	Landau, Heather, MD

Title